Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates.
Acetamido derivatives of the naturally antibacterial non-β-lactam lactivicin (LTV) have improved activity against their penicillin binding protein targets and reduced hydrolysis by β-lactamases, but penetration into Gram-negative bacteria is still relatively poor. Here we report that modification of...
Главные авторы: | Calvopiña, K, Umland, K, Rydzik, A, Hinchliffe, P, Brem, J, Spencer, J, Schofield, C, Avison, M |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
American Society for Microbiology
2016
|
Схожие документы
-
Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates
по: Calvopiña, K, и др.
Опубликовано: (2017) -
Stenotrophomonas maltophilia in Salad
по: Andleeb Qureshi, и др.
Опубликовано: (2005-07-01) -
Structural basis for the interaction of lactivicins with serine beta-lactamases.
по: Brown, T, и др.
Опубликовано: (2010) -
Effect of Stenotrophomonas maltophilia on Tuberculosis
по: Yue Li, и др.
Опубликовано: (2023-08-01) -
Stenotrophomonas maltophilia: An emerging pathogen in sepsis
по: J S Soumya, и др.
Опубликовано: (2020-01-01)